SCHEMBL22552932

SCHEMBL22552932

CCCCC(O)C(CCCC)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.50
MAPK1 P28482 1/20 0.50
GPR84 Q9NQS5 7/20 0.48
FFAR1 O14842 2/20 0.48
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
MAPT P10636 1/20 0.42
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
CHRM1 P11229 1/20 0.41
AKR1A1 P14550 1/20 0.41
CHRM3 P20309 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41
HRH1 P35367 1/20 0.41
DRD3 P35462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22552930 1.00 CA2 (0.50) CA2MAPK1GPR84FFAR1SLC1A3
SCHEMBL24257290 0.96 GPR84 (0.55) CA2MAPK1GPR84FFAR1MAPT
SCHEMBL27334962 0.96 GPR84 (0.55) CA2MAPK1GPR84FFAR1MAPT
SCHEMBL21550839 0.94 GPR84 (0.59) GPR84FFAR1MAPTLCKPPARD
SCHEMBL28954259 0.93 CA2 (0.48) CA2MAPK1GPR84FFAR1SLC1A3
SCHEMBL48780 0.93 CA2 (0.48) CA2MAPK1GPR84FFAR1SLC1A3
SCHEMBL5054302 0.91 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD
SCHEMBL21679654 0.91 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD
SCHEMBL11806278 0.91 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD
SCHEMBL8917383 0.91 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681875-B1 CYCLIC PEPTIDE ANTIBIOTICS HOFFMANN LA ROCHE (CH) 2026-01-14 EP disclosed
US-11279735-B2 Cyclic peptide antibiotics GENENTECH, INC. (US) 2022-03-22 US disclosed
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS GENENTECH, INC. (US) 2020-10-22 US disclosed
CN-111148739-A Cyclopeptide antibiotics 豪夫迈·罗氏有限公司 2020-05-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS NPPA, LNPEP, CLPP CA2 3912/4885MAPK1 1114/4885GPR84 2132/4885
US-11279735-B2 Cyclic peptide antibiotics NPPA, LNPEP, CLPP CA2 3912/4885MAPK1 1114/4885GPR84 2132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.